孟鲁司特钠联合氯雷他定治疗小儿咳嗽变异性哮喘的疗效研究

Montelukast Sodium joint Loratadine Treatment of Children with Cough Variant Asthma Observed

目的对孟鲁司特钠联合氯雷他定治疗小儿咳嗽变异性哮喘的效果进行研究,总结经验和不足,以更好地指导临床应用。方法选取我院2010年2月—2012年2月小儿咳嗽变异性哮喘75例,分成A、B两组。A组(32例)患儿给予氯雷他定治疗;B组(43例)患儿在A组基础上加孟鲁司特钠治疗。将A、B组患儿治疗后病症改善情况和病情恢复效果等进行研究。结果 B组患儿咳嗽痊愈天数、哮喘持续天数及肺部鸣音痊愈天数均少于A组患儿,不良反应发生率低于A组患者。结论孟鲁司特钠联合氯雷他定治疗小儿咳嗽变异性哮喘效果显著,患者病情恢复良好,有效率较高,不良反应发生率较低,具有较高使用和推广价值。

Objective That he will be on the the montelukast sodium Joint loratadine effect of treatment of children with cough variant asthma study,sum up experience and inadequate,to better guide the clinical application. Methods Random selection in our hospital from February 2010 to February 2012 the B group of 43 children with cough variant asthma 75,divided into A,B two groups,A group of 32 children to the control group,given loratadine treatment;sufferingchildren for the treatment group,on the basis of group A Jiameng Lu Division special sodium treatment,the A and B patients after treatment the disease to improve the situation and condition recovery effect,treatment efficiency study. Results Group B children with cough cured a number of days,The asthmaticus days and lung beep recovered days are less than A group of children,the treatment efficiency is higher than in group A,the incidence of adverse reactions is lower than in group A patients. Conclusion Montelukast sodium Joint loratadine treatment of children with cough variant asthma effect a significant recovery of the patient′s condition good,efficient,low incidence of adverse reactions with higher use and promotion of value.